Clinical Trial Update: A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for AL8326 in Small Cell Lung Cancer spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• AL8326

Snippet

Sponsor: Advenchen Laboratories Nanjing Ltd. | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN